None Injection American McGaw Anesthetic 5-C 3-30-84 Lidocaine HCI & 5% Dextrose Injection Verapamil NCI Calan 1.V. Vials Sear le Supraventricular Tachy-Arrhythmias 5-C 3-30-84 19-077 None In jection American McGaw 5-C-P 3-02-84 Sterile Water for Diluent for other 18-938 De smopressin Acetate DDAVP Injection Ampuls Armour 3-B 3-30-84 Anti-diuretic used 18-907 Metronidazole Red I- Infusion Vial Elkins-Sinn 5-C 3-30-84 Treatment of serious 18-967 18-704 Metoprolol 1.opressor Injection Ciba-Geigy 3-B Anti-hypertensive 3-30-84 18-925 19-038 Verapamil HCI Calan 1.v. Syringes Searle Pharms Supraventricular Tachy-Arrhythmias 5-C 3-30-84 April 1984 NDA! 18-985 19-004 19-006 18-921 18-901 18-849 18-977 18-858 18-776 Yecuronium Bromide Morcuron (NC-45) Injection Organon Inc. Neuromuscular block ing agent: 04-30-84 NDAS APP DOSAGE CLASSIF- APPRUTAL TRADE NAME APPLICANT INDICATIONS DATE Micronase Tablet Upjohn 05-01-84 . bia Beta Tablet Hoechst-Roussel 5-C 05-01-84 Hypoglycemia Sufenta 05-04-84 Marcaine 3-C Bupivacaine HCI .75% with Dextrose 05-04-84 Injection Janssen Sterling Zenith Labs None Anti-inflammatory 5-C-U 05-04-84 None Anti-allergic . 5-C 05-04-84 Phenylpropanolamine HCI & Chlorpheniramine Maleate NDA! GENERIC NAME May 1984 17-498 Glyour ide 17-532 19-050 Sufentan 11 18-692 18-730 Indomethacin 18-809 17-783 Tablet 18-556 61 ipizide Glucotrol Advil 18-804 18-989 Tablet 19-012 18-851 Indomethacin 50-579 Cefonicid Sodiun 50-554 Ceforan ide * It has been determined that the modest advance rating will be attributed to the first application approved when two applications are approved on the same date for the same use. David Beier, Esq. and the Administration of Justice Subject: Ad Hoc Group to Improve the Patent Laws -- Dear David: Concurrent with our preparation of testimony, we are collecting materials in response to your inquiry about background for the items in our proposed patent legislation. One of the areas for which we are seeking legislative remedy has to do with the effect, on the patentability of subsequent inventions, of background scientific knowledge within an organization. This situation has led to conflicting judicial decisions over the past decade. Our concern is for the effect of such decisions on team research and the free exchange of scientific information within research organizations. There has been extensive scholarly analysis of this situation, and several excellent reviews of the law have recently been published. Copies are enclosed. There is now extensive discussion within the bar associations of this issue, and several good suggestions have been made to improve the language of the Ad Hoc Group. We look forward to discussing this with you, because we would like to include all useful suggestions in the bill as introduced. We will write to you separately on the other sections of the proposed bill. Encl. Shurn, "Is the Invention of Another Available as Prior Art? In re Bass to In re Clemens and Beyond", 63 Journal of the Patent Office Society 516 (1981). Walterscheid, "The Ever Evolving Meaning of Prior Art", Part I, 64 J.P.0.8. 457 (1982) Ad Hoc Group to Improve the Patent Laws CC: d51B5 md 73 |